To investigate the predictive capacity of a systemic immune-inflammation index (SII) in detecting new-onset atrial fibrillation (NOAF) following ST segment elevation myocardial infarction (STEMI). A total of 402 STEMI patients were enrolled in the study. The patients were divided into two groups according to NOAF development. A cut-off point of 1,228,000 for SII was identified with 60% sensitivity and 78.1% specificity to predict NOAF following STEMI. According to pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting NOAF following STEMI was similar to high-sensitive C-reactive protein, and better than neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio. SII can be used as one of the independent predictors of NOAF following STEMI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/bmm-2020-0838 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction.
J Interv Card Electrophysiol
December 2024
Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Background: New-onset atrial fibrillation (NOAF) complicating ST-segment elevation myocardial infarction (STEMI) remains clinically challenging. The aim of this study was to assess the incidence of NOAF, identify risk factors for the development of atrial fibrillation (AF), and analyze the impact on patient care, therapy, and outcomes during long-term follow-up.
Methods: This retrospective single-center study reviewed consecutive patients undergoing coronary angiography (CAG) for acute STEMI between May 2015 and September 2023.
Predictive value of platelet-to-albumin ratio combined with the CHEST score for New-Onset atrial fibrillation in elderly patients with acute ST-segment elevation myocardial infarction.
BMC Cardiovasc Disord
September 2024
Department of Geriatric Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Background: New-onset atrial fibrillation (NOAF) is a common adverse outcome in acute ST-segment elevation myocardial infarction (STEMI) patients following percutaneous coronary intervention (PCI) and is associated with a worse prognosis. The platelet-to-albumin ratio (PAR) has been utilized to predict the severity and prognosis of cardiovascular diseases. This study aims to investigate the predictive value of PAR combined with the CHEST score for NOAF in the elderly population with STEMI undergoing PCI.
View Article and Find Full Text PDFPrognostic impact of new-onset atrial fibrillation in myocardial infarction with and without improved ejection fraction.
ESC Heart Fail
December 2024
Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Aims: Improvement in left ventricular ejection fraction (impEF) often presents in contemporary acute myocardial infarction (AMI) patients. New-onset atrial fibrillation (NOAF) during AMI is an important predictor of subsequential heart failure (HF), while its impact on the trajectory of post-MI left ventricular ejection fraction (LVEF) and prognostic implication in patients with and without impEF remains undetermined. We aimed to investigate the prognostic impacts of NOAF in AMI patients with and without impEF.
View Article and Find Full Text PDFIncidence and predictors of new-onset atrial fibrillation in ST-elevation myocardial infarction: A single-center study.
Health Sci Rep
July 2024
Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran.
Background And Aims: Atrial fibrillation (AF) is a common arrhythmia that occurs following ST-elevation myocardial infarction (STEMI) and can significantly impact clinical outcomes. We investigated the incidence and predictors of AF following STEMI in patients, as well as its association with major adverse cardiac and cerebrovascular events (MACCE).
Methods: We conducted a retrospective cohort study, including all STEMI patients who presented under code 247 to Tehran Heart Center between 2016 and 2020 and completed a 1-year follow-up.
Association of lipopolysaccharide with new-onset atrial fibrillation in ST-segment elevation myocardial infarction.
Heliyon
March 2024
Department of Cardiology, Huai'an Second People's Hospital, 223001, Jiangsu, China.
Background: Lipopolysaccharide (LPS) is related to various cardiovascular diseases. However, the relationship between LPS and new-onset atrial fibrillation (NOAF) after ST-segment elevation myocardial infarction (STEMI) has yet to be elucidated. This study aimed to evaluate the impact of LPS on NOAF in STEMI patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!